ShareValue scores for MOBI: Valuation 48, Quality 29, Growth 58, Health 43.

MOBI
NASDAQ

Mobia Medical, Inc. Common Stock

$12.32(+0.57%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 17%
Valuation
48
Fair Value
Price vs Value
Quality
29
Weak
Business Strength
Growth
58
Moderate
Revenue & Earnings
Health
43
Moderate
Financial Stability
Momentum
43
Neutral
Price Trend

Company Details

About

Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas. Address: 2802 Flintrock Trace, Austin, TX, United States, 78738

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026